You are here » Home » Company » Natco Pharma Ltd

Natco Pharma Ltd.

BSE: 524816 Sector: Health care
NSE: NATCOPHARM ISIN Code: INE987B01026
BSE 00:00 | 19 Apr 799.85 -6.45
(-0.80%)
OPEN

800.00

HIGH

810.00

LOW

794.70

NSE 00:00 | 19 Apr 802.60 1.60
(0.20%)
OPEN

808.95

HIGH

809.75

LOW

792.80

OPEN 800.00
PREVIOUS CLOSE 806.30
VOLUME 25260
52-Week high 1080.00
52-Week low 671.25
P/E 25.47
Mkt Cap.(Rs cr) 14,757
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 800.00
CLOSE 806.30
VOLUME 25260
52-Week high 1080.00
52-Week low 671.25
P/E 25.47
Mkt Cap.(Rs cr) 14,757
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Natco Pharma Ltd.

Natco Pharma Ltd

Incorporated in Sep.'81 as Natco Fine Pharmaceutical Ltd, it became a deemed public company with effect from Jul.'92 and in Feb.'93, it changed its name to Natco Pharma (NPL). NPL began to manufacture conventional and time-release dosage forms of life-saving drugs. NPL is a contract manufacturer for reputed companies like Ranbaxy and Parke Davis. It has also obtained the coveted ISO 9002 certifica...> More

Natco Pharma Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   14,757
EPS - TTM () [*S] 31.40
P/E Ratio (X) [*S] 25.47
Face Value ()   2
Latest Dividend (%)   350.00
Latest Dividend Date 15 Feb 2018
Dividend Yield (%) 0.80
Book Value / Share () [*S] 150.54
P/B Ratio () [*S] 5.31
[*C] Consolidated     [*S] Standalone    

Natco Pharma Ltd - Financial Results

Particulars ( cr) Dec 2017 Dec 2016 % Chg
Net Sales 562.2 669.9 -16.08
Other Income 11.4 6.1 86.89
Total Income 573.6 676 -15.15
Total Expenses 275.7 409.7 -32.71
Operating Profit 297.9 266.3 11.87
Net Profit 217.4 194.9 11.54
Equity Capital 36.9 34.9 -
> More on Natco Pharma Ltd Financials Results

Natco Pharma Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alkem Lab 1799.70 1.12 21515.41
Glaxosmi. Pharma 2378.25 0.79 20143.78
Glenmark Pharma. 565.05 -0.34 15945.71
Natco Pharma 799.85 -0.80 14757.23
Abbott India 6162.70 -0.31 13095.74
Syngene Intl. 650.15 3.49 13003.00
Jubilant Life 781.00 -2.09 12441.33
> More on Natco Pharma Ltd Peer Group

Natco Pharma Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 48.37
Banks/FIs 0.40
FIIs 23.96
Insurance 0.00
Mutual Funds 5.67
Indian Public 17.76
Custodians 0.00
Other 3.59
> More on Natco Pharma Ltd Share Holding Pattern

Natco Pharma Ltd - Research Reports

Date Broker Action Price Report
07/11 Equirus Securities Accumulate 957 PDF IconDetails
> More on Natco Pharma Ltd Research Reports

Natco Pharma Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 2.89% 3.37% 0.96% 1.02%
1 Month 4.66% 5.17% 4.57% 4.67%
3 Month -21.19% -21.50% -3.05% -3.02%
6 Month -19.02% -18.68% 6.29% 4.13%
1 Year -17.05% -16.96% 17.35% 16.06%
3 Year 70.56% 71.51% 21.04% 22.77%

Natco Pharma Ltd - STOCK STRENGTH

Today's Low/High 794.70
810.00
Week Low/High 772.00
828.00
Month Low/High 743.00
828.00
YEAR Low/High 671.25
1080.00
All TIME Low/High 1.60
1080.00